PARSIPPANY, N.J.--(BUSINESS WIRE)--Aug. 7, 2012--
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that David
Stack, president and chief executive officer of Pacira Pharmaceuticals,
is scheduled to present at the Wedbush PacGrow 2012 Life Sciences
Management Access Conference on Tuesday, August 14, 2012, at 8:35 a.m.
ET at Le Parker Meridien in New York. Mr. Stack is expected to present
an overview of the company.
A live audio webcast of the Pacira presentation can be accessed by
visiting the “Investors & Media” section of the company's website at investor.pacira.com.
A replay of the webcast will be archived on the Pacira website for two
weeks following the presentation date.
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is an emerging specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company's current emphasis is the
development of non-opioid products for postsurgical pain control, and
its lead product, EXPAREL® (bupivacaine liposome injectable suspension),
was commercially launched in the United States in April 2012. EXPAREL
and two other approved products utilize the Pacira proprietary product
delivery technology DepoFoam®, a unique platform that encapsulates drugs
without altering their molecular structure and then releases them over a
desired period of time. Additional information about Pacira is available
Source: Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.
James S. Scibetta, 973-254-3570